Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 1.000 | |
| 4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.517 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.504 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.502 | |
| 3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.493 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.489 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.487 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.484 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.480 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.480 | |
| 4uxq | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.480 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.479 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.478 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.477 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.474 | |
| 3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.472 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.469 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.469 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.468 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.467 | |
| 3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.467 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.467 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.465 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.465 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.463 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.462 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.462 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.461 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.459 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.457 | |
| 3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.457 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.456 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.452 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.452 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
| 4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.450 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.447 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.447 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.447 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.447 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.447 | |
| 4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.447 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.445 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.445 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.444 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.444 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.444 | |
| 3dh7 | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.443 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.443 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
| 5dp2 | NAP | CurF | / | 0.442 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.441 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.441 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.441 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 |